CEUFAST COURSE

Angina

Contact Hours:1.5 Contact Hours, including 1.5 Pharmacology Hours  Author:  Krystle Maynard (DNP, RN, SANE-A) This peer-reviewed course is applicable for the following professions:Advanced Practice Registered Nurse (APRN), CCI Credential...

Course Summary

Contact Hours:
1.5 Contact Hours, including 1.5 Pharmacology Hours  

Author:  
Krystle Maynard (DNP, RN, SANE-A) 

This peer-reviewed course is applicable for the following professions:

Advanced Practice Registered Nurse (APRN), CCI Credentialed Specialists, Certified Nurse Midwife, Certified Nurse Practitioner, Certified Registered Nurse Practitioner, Clinical Nurse Specialist (CNS), Licensed Practical Nurse (LPN), Licensed Vocational Nurses (LVN), Midwife (MW), Nursing Student, Registered Nurse (RN), Registered Nurse Practitioner 

 Accreditations: 

The American Nurses Credentialing Center (ANCC)

State Approvals:

Alabama, Provider #ABNP1485; California BRN Provider #CEP # 13509; Kentucky Board of Nursing Provider #7-0085; Florida Board of Nursing Provider 50-353

Course Description:  

This course discusses the various types of angina, its pathophysiology, common (and uncommon) causes of angina/chest pain, nursing management, and diagnostics. 

Outcomes:  

≥ 92% of participants will know what angina is, its types, common causes, diagnostics, and management. 

Objectives:  

After completing this continuing education course, the participant will be able to:  

  1. Define the different types of angina and their underlying pathophysiology.

  2. Identify common signs and symptoms associated with angina, including atypical presentations.

  3. Differentiate between stable, unstable, and variant (Prinzmetal's) angina.

  4. Describe evidence-based nursing assessments and interventions for patients presenting with angina.

  5. Summarize pharmacologic and non-pharmacologic management strategies for angina. 

Disclosures:  

CEUFast Inc. and the course planning team for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.